John Kelton - McMaster Experts

Affiliations

Faculty of Health Sciences, McMaster University
Member, McMaster Centre for Transfusion Research (MCTR), Faculty of Health Sciences
Professor, Medicine, Faculty of Health Sciences
Joint Appointment, Pathology & Molecular Medicine, Faculty of Health Sciences
Executive Director, Michael G. DeGroote Initiative for Innovation in Healthcare, McMaster University
Executive Director, Marnix E. Heersink School of Biomedical Innovation & Entrepreneurship, McMaster University

Scholarly Activity in McMaster Experts

Co-author Network

Scholarly Activity
Background
Contact
View All

selected scholarly activity

books
- Blood Transfusion A Conceptual Approach 1984
chapters
- Acetylsalicylic acid for the prevention and treatment of thromboembolic diseases. 619-633. 2016
- Red cell, platelet, and white cell antigens. 509-546. 2013
- Acquired hemolytic anemia. 157-172. 2011
- Acquired hemolytic anemia. 157-172. 2011
- CHAPTER 10 Acquired hemolytic anemia. 157-172. 2011
- Disorders of platelet number and function. 4506-4518. 2010
- Thrombocytopenia in pregnancy. 374-392. 2006
- Immune-mediated thrombocytopenia. 542-555. 2002
- The Effect Of Heparin Upon Complement Activation. 101-119. 1980
conferences
- Pathogenic Antibodies in Heparin-Induced Thrombocytopenia Specifically Target an Immunodominant Region on Platelet Factor 4. Blood. 219-219. 2019
- Perioperative Eltrombopag or Intravenous Immune Globulin for Patients with Immune Thrombocytopenia: A Multicenter Randomized Trial. Blood. 896-896. 2019
- Autoantibodies to thrombopoietin and the thrombopoietin receptor in patients with immune thrombocytopenia. Blood. 234-241. 2018
- Emergency Management of Patients with Immune Thrombocytopenia and Severe Bleeding. Blood. 2017
- Performance Characteristics of a Novel Platelet Viability Assay for Heparin-Induced Thrombocytopenia. Blood. 2017
- The Identification of the Amino Acids on Platelet Factor 4 That Bind Pathogenic Antibodies in Heparin-Induced Thrombocytopenia. Blood. 2017
- Megakaryocyte Apoptosis in the Bone Marrow of Patients with Immune Thrombocytopenia. Blood. 1379-1379. 2016
- A Phase II Study Evaluating the Efficacy of Rituximab in the Management of Patients with Relapsed or Refractory TTP. Blood. 4191-4191. 2014
- The Mcmaster ITP Registry: Assessing the Prevalence, Clinical and Laboratory Features of Immune Thrombocytopenia. Blood. 5008-5008. 2014
- lLow Level Platelet-Activating Antibodies in Patients Suspected of Having Heparin-Induced Thrombocytopenia but Testing Negative in the "Gold Standard" Functional Test. Blood. 2014
- Persistent Impairments in Humoral and Cellular Immunity in Patients with Immune Thrombocytopenia Treated with Rituximab: A Sub-Study of a Randomized Controlled Trial. Blood. 2012
- Persistent Impairments in Humoral and Cellular Immunity in Patients with Immune Thrombocytopenia Treated with Rituximab: A Sub-Study of a Randomized Controlled Trial. Blood. 492-492. 2012
- Bone Marrow Specimens From Patients with Immune Thrombocytopenia (ITP) Demonstrate Increased Megakaryocyte-Bound IgG and Increased T-Helper Cells. Blood. 972-972. 2011
- Identifying Drugs Implicated in Drug-Induced Immune Thrombocytopenia Using Levels of Evidence Applied to Laboratory Tests. Blood. 1421-1421. 2011
- A RANDOMIZED, DOUBLE-BLIND STUDY TO ASSESS SERUM TRANSAMINASE ELEVATIONS AND ANTIBODY FORMATION FOLLOWING REPEAT SUBCUTANEOUS DOSING OF LMWH, UFH OR THE NOVEL ANTICOAGULANT M118 IN HEALTHY VOLUNTEERS.. Clinical Pharmacology and Therapeutics. S72-S72. 2011
- The Utility of Bone Marrow Examinations for the Diagnosis of Immune Thrombocytopenia. Blood. 1514-1514. 2010
- Understanding Treatment Preferences In Patients with Primary Immune Thrombocytopenia Contemplating Splenectomy: A Qualitative Study. Blood. 176-176. 2010
- Passive Transfer of Hepatitis B Core Antibody by Intravenous Immune Globulin-in Patients with Immune Thrombocytopenic Purpura. Blood. 955-955. 2009
- Autoantibodies in Patients with ITP Do Not Bind to Patient-Specific Epitopes on Platelet Glycoproteins. Blood. 1175-1175. 2008
- The Efficacy of H. pylori Eradication Therapy in H. pylori-Infected and Uninfected Patients with Immune Thrombocytopenic Purpura: A Systematic Review. Blood. 1170-1170. 2008
- Refractory thrombotic thrombocytopenic purpura in a patient with waldenstroms macroglobulinemia. Transfusion. 49A-50A. 2008
- An individual platelet count set-point in ITP: A concept learned from patients with mild thrombocytopenia and a good response to IVIg or corticosteroids. Blood. 49B-49B. 2007
- Incidence of HPA-9b in Testing for Neonatal Alloimmune Thrombocytopenia.. Blood. 3214-3214. 2007
- Peripartum Management of Women with Suspected Hereditary Thrombocytopenia.. Blood. 3224-3224. 2007
- An algorithm for "indeterminate" test results in the platelet serotonin release assay for heparin-induced thrombocytopenia (HIT).. Blood. 312A-312A. 2006
- Platelet-activating anti-platelet factor 4/polyanion antibodies without preceding heparin therapy: A transient autoimmune disorder resembling heparin-induced thrombocytopenia ("spontaneous HIT").. Blood. 311A-312A. 2006
- Intravenous immunoglobulin as an adjunct to plasma exchange for the treatment of chronic thrombotic thrombocytopenic purpura: A case report. Transfusion. 44A-45A. 2006
- A revisit of the criteria to define remission in patients with idiopathic thrombocytopenia undergoing splenectomy.. Blood. 846A-846A. 2005
- Intravenous gamma globulin does not increase RNA of FcgRIIb in purified human monocytes.. Blood. 52B-53B. 2005
- Mechanisms of static and shear-induced platelet adhesion: Differences in the adhesion supported by MMRN1 comparisons with other beta 3 integrin ligands.. Blood. 746A-746A. 2005
- Rituximab for the treatment of adults with ITP: A systematic review. Blood. 361A-361A. 2005
- The HPA-15 (Gov) Platelet Alloantigen System: Allele Frequencies in the Canadian Population.. Blood. 2180-2180. 2005
- Laboratory testing for HIT antibodies: How much class do we need?. Blood. 825A-826A. 2004
- Triple Immunosuppressive Therapy in Patients with Chronic Resistant Immune Thrombocytopenic Purpura; a Case Series of 11 Patients.. Blood. 2059-2059. 2004
- Comparison of heparin-induced thrombocytopenia antibody (HIT-Ab) generation and in vitro cross-reactivity after elective hip or knee replacement surgery in patients receiving Antithrombotic prophylaxis with fondaparinux or enoxaparin.. Blood. 164A-164A. 2003
- Demonstration of platelet engraftment by platelet genotyping after HPA-mismatched allogeneic peripheral blood transplantation. Blood. 967A-967A. 2003
- Effect of fondaparinux on platelet activation in the presence of heparin-dependent anti-platelet antibodies. A blinded comparative multicenter study with unfractionated heparin.. Blood. 319A-319A. 2003
- Homozygous inheritance of the Cys8Arg mutation in the amino-terminal region of platelet glycoprotein IX in a family with Bernard-Soulier syndrome.. Blood. 784A-785A. 2003
- Subclass analysis of Anti-Ib/IX autoantibodies in patients with idiopathic thrombocytopenic purpura.. Blood. 294A-295A. 2003
- Dissociation of vWF-cleaving protease activity and platelet count in a patient with familial thrombotic thrombocytopenia purpura.. Blood. 685A-685A. 2002
- Genetic polymorphisms in the noncoding sequences of the PF4 and PF4alt genes are not associated with the development of heparin-induced thrombocytopenia.. Blood. 687A-687A. 2002
- Immunization to platelet alloantigens: A ten-year retrospective study.. Blood. 482A-483A. 2002
- Evaluation of whole blood derived platelets stored as a pool for 7 days.. Transfusion. 11S-11S. 2002
- A novel universal antigen capture assay to measure platelet-bound autoantibodies in immune thrombocytopenic purpura.. Blood. 520A-520A. 2001
- Effect of splenectomy in patients with chronic idiopathic thrombocytopenic purpura.. Blood. 524A-524A. 2001
- Efficacy of a novel IGIV preparation in the treatment of acute and chronic ITP.. Blood. 523A-523A. 2001
- Evaluation of whole blood derived platelets stored as a pool.. Blood. 449A-449A. 2001
- Subclass distribution of platelet bound anti-GPIIbIIIa autoantibodies in immune thrombocytopenic purpura.. Blood. 522A-522A. 2001
- The predictors of clinical outcome in patients with heparin-induced thrombocytopenia.. Blood. 36A-36A. 2001
- Trafficking of autoantibodies in platelets from ITP patients: Investigation using glycoprotein-specific assays.. Blood. 521A-521A. 2001
- Variable expression of platelet GPIb-IX-V subunits in a family with Bernard-Soulier Syndrome.. Blood. 253A-253A. 2001
- A prospective cross-sectional study to characterize selected autoimmune (AI) markers and report the incidence of antithrombopoietin antibodies (alpha TPO) in patients with immune thrombocytopenic purpura (ITP).. Blood. 250A-250A. 2000
- Decreased von Willebrand factor proteolytic activity associated with thrombocytopenic disorders.. Blood. 531A-531A. 2000
- Evaluation of platelet morphology and the subcellular distribution of PAIgG in patients with ITP and non-immune thrombocytopenia.. Blood. 249A-249A. 2000
- Expression of CD109 with alternate forms of membrane anchoring unique to platelets and megakaryocytic cell lines.. Blood. 55B-55B. 2000
- IgG subclass evaluation of antibodies against specific platelet glycoprotein IIb/IIIa using antigen capture technique.. Blood. 63B-63B. 2000
- In vitro time-dependent changes of surface PAIgG in ITP and non-immune thrombocytopenia.. Blood. 65B-65B. 2000
- Possible pathways of IgG trafficking in platelets.. Blood. 250A-250A. 2000
- The impact of idiopathic thrombocytopenic purpura in pregnancy.. Blood. 248A-248A. 2000
- Transience of heparin-induced thrombocytopenia antibodies.. Blood. 531A-531A. 2000
- Treatment of chronic refractory idiopathic thrombocytopenic purpura with cyclophosphamide and cyclosporine.. Blood. 253A-253A. 2000
- Bivalirudin during percutaneous coronary intervention in patients with heparin-induced thrombocytopenia: Interim results of the ATBAT trial.. American Journal of Cardiology. 73I-74I. 2000
- Evaluation of clot formation in AS-3 red cells diluted with Ringer's Lactate. Transfusion. 132S-132S. 2000
- Prevention of febrile non-hemolytic transfusion reactions in children: A randomized controlled trial. Transfusion. 20S-20S. 2000
- Discussion. Clinical and Investigative Medicine. 52-54. 2000
- A dipstick assay for diagnosis of heparin-induced thrombocytopenia (HIT).. Blood. 80B-80B. 1999
- Evaluation of clot formation in AS-3 red cells diluted with Ringer's lactate.. Blood. 461A-461A. 1999
- Morphological investigation of microparticle generation in heparin-induced throbocytopenia using confocal microscope and electron microscopy.. Blood. 16A-16A. 1999
- Proteolysis of human platelet FcRIIa during activation induced by heparin-induced thrombocytopenia (HIT) sera.. Blood. 442A-442A. 1999
- Subclass restriction of autoantibodies in patients with idiopathic thrombocytopenic purpura.. Blood. 19A-19A. 1999
- Importance of patient population in the frequency of HIT: A comparison of activation and antigen assays. Thrombosis and Haemostasis. 363-364. 1999
- The clinical management of heparin-induced thrombocytopenia. Seminars in Hematology. 17-21. 1999
- Comparison of the clinical utility of the platelet function analyzer (PFA-100 (TM)) and standard bleeding time in patients with hemostatic disorders.. Blood. 90B-90B. 1998
- Phospholipase digestion and detergent solubility define two distinct populations of platelet CD109.. Blood. 74B-74B. 1998
- Role of the platelet FcRIIa polmorphism in idiopathic thrombocytopenia purpura (ITP).. Blood. 85B-85B. 1998
- Severe neonatal alloimmune thrombocytopenia due to a novel low-frequency alloantigen, Dy-a.. Blood. 180A-180A. 1998
- The study of PAIgG distribution in patients with immune and nonimmune thrombocytopenia using confocal microscopy.. Blood. 176A-177A. 1998
- Timing of heparin-induced thrombocytopenia (HIT) in relation to previous heparin use: Absence of an anamnestic immune response, and implications for repeat heparin use in patients with a history of HIT.. Blood. 182A-182A. 1998
- A prospective study of antigen capture assays for the investigation of idiopathic thrombocytopenic purpura (ITP).. Blood. 2037-2037. 1997
- Measurement of endogenous and exogenous alpha granular platelet proteins in patients with immune and nonimmune thrombocytopenia.. Blood. 2040-2040. 1997
- Persistence of anti-glycoprotein IIb/IIIa antibodies in patients in complete remission from idiopathic thrombocytopenic purpura (ITP).. Blood. 2038-2038. 1997
- Sequestration of the Gov alloantigens into low density high molecular weight membrane fractions isolated from human platelets.. Blood. 3029-3029. 1997
- The role of heparin-induced thrombocytopenia (HIT) in the thrombocytopenia and thrombotic events in chronic hemodialysis (HD) patients.. Journal of the American Society of Nephrology. A1150-A1150. 1997
- Factor V Leiden and thrombotic complications in heparin-induced thrombocytopenia. Thrombosis and Haemostasis. P1287-P1287. 1997
- ABH antigens are expressed on the GPI-anchored protein, CDw109, on human platelets.. Blood. 1270-1270. 1996
- Maternal alloimmunization to the Gov(a)/Gov(b) antigens on human platelets.. Blood. 1271-1271. 1996
- Measurement of platelet procoagulant activity in heparin induced thrombocytopenia.. Blood. 3011-3011. 1996
- The human HPA-1 alloantigen system is absent on murine platelets.. Blood. 2934-2934. 1996
- Acute transfusion reactions in pediatric patients.. Blood. 3407-3407. 1995
- Alloimmune thrombocytopenia in two recipients of kidney transplants from same donor.. Blood. 255-255. 1995
- Calpain activity in bone marrow transplant-associated thrombotic microangiopathy (BMT-TM).. Blood. 867-867. 1995
- Epitope specificity of the antibodies in sera of patients with heparin induced thrombocytopenia.. Blood. 2138-2138. 1995
- FC(gamma)IIA receptor genotype heterogeneity and platelet activation by heparin-induced thrombocytopenia IgG (HIT-IgG): A possible explanation for the predominance of the ''low responder'' (his(131)) Fc(gamma)IIA receptor genotype in HIT patients.. Blood. 2136-2136. 1995
- Formation of heparin-induced thrombocytopenia IgG (HIT-IgG) without thrombocytopenia: Analysis of a clinical trial.. Blood. 2137-2137. 1995
- Isolation and characterization of cysteine protease in thrombotic thrombocytopenic purpura.. Blood. 1134-1134. 1995
- Lightning strikes twice: Glanzmann's thrombasthenia in two half-sisters.. Blood. 3576-3576. 1995
- Multimerin deficiency in a second Quebec family.. Blood. 2186-2186. 1995
- Splenectomy reduces the frequency of relapse in patients with chronic relapsing TTP.. Blood. 343-343. 1995
- VENOUS LIMB GANGRENE COMPLICATING HEPARIN-INDUCED THROMBOCYTOPENIA - IMPLICATIONS FOR TRANSFUSION MEDICINE. Transfusion. S97-S97. 1995
- IDENTIFICATION OF AN AUTOSOMAL-DOMINANT BLEEDING DISORDER WITH A COMBINED DEFICIENCY OF PLATELET MULTIMERIN AND PLATELET FACTOR-V. Thrombosis and Haemostasis. 1190-1190. 1995
- THE CDNA SEQUENCE OF HUMAN ENDOTHELIAL-CELL MULTIMERIN - A NOVEL PROTEIN WITH RGDS, COILED-COIL, AND EGF DOMAINS, AND A CARBOXYL-TERMINUS SIMILAR TO THE GLOBULAR DOMAINS OF COMPLEMENT C1Q. Thrombosis and Haemostasis. 1054-1054. 1995
- WARFARIN TREATMENT OF DEEP-VEIN THROMBOSIS COMPLICATING HEPARIN-INDUCED THROMBOCYTOPENIA (HIT) IS A RISK FACTOR FOR INITIATION OF VENOUS LIMB GANGRENE - REPORT OF 9 PATIENTS IMPLICATING THE INTERACTING PROCOAGULANT EFFECTS OF 2 ANTICOAGULANT AGENTS. Thrombosis and Haemostasis. 1110-1110. 1995
- A PROSPECTIVE-STUDY OF HEPARIN-INDUCED THROMBOCYTOPENIA - UNFRACTIONATED HEPARIN COMPARED WITH LOW-MOLECULAR-WEIGHT HEPARIN. Blood. A188-A188. 1994
- CYCLOHEXIMIDE AND ACTINOMYCIN INHIBIT CYTOKINE ACCUMULATION DURING PLATELET CONCENTRATE STORAGE. Blood. A463-A463. 1994
- DETECTION OF PLATELET-ASSOCIATED AUTOANTIBODIES TO THE GP-IIB/IIIA COMPLEX BY DIRECT RADIOIMMUNO-PRECIPITATION - A SPECIFIC TEST FOR IDIOPATHIC THROMBOCYTOPENIC PURPURA. Blood. A185-A185. 1994
- EVALUATION OF THE FC RECEPTOR IIA GENOTYPE FREQUENCIES AMONG PATIENTS WITH HEPARIN-INDUCED THROMBOCYTOPENIA. Blood. A661-A661. 1994
- FACTOR-V IS COMPLEXED WITH MULTIMERIN IN RESTING PLATELET LYSATES AND COLOCALIZES WITH MULTIMERIN WITHIN PLATELET ALPHA-GRANULES. Blood. A387-A387. 1994
- HEPARIN-INDUCED THROMBOCYTOPENIA - PREDOMINANCE OF VENOUS THROMBOTIC COMPLICATIONS, AND A HIGH-RISK FOR SUBSEQUENT THROMBOSIS IN PATIENTS WHO ARE INITIALLY RECOGNIZED WITH ISOLATED THROMBOCYTOPENIA. Blood. A188-A188. 1994
- HETEROGENEITY OF THE MEMBRANE ANCHOR FOR GP175 EXPRESSING THE GOV ALLOANTIGEN SYSTEM. Blood. A472-A472. 1994
- IDENTIFICATION OF AN AUTOSOMAL-DOMINANT BLEEDING DISORDER THAT IS ASSOCIATED WITH A DEFICIENCY OF PLATELET MULTIMERIN AND A DEFECT IN PLATELET FACTOR-V. Blood. A110-A110. 1994
- THE CDNA SEQUENCE OF HUMAN ENDOTHELIAL-CELL MULTIMERIN - A NOVEL PROTEIN WITH RGDS, COILED-COIL, AND EGF DOMAINS, AND A CARBOXYL-TERMINUS SIMILAR TO THE GLOBULAR DOMAINS OF THE TRIMERIC PROTEINS C1Q AND COLLAGENS TYPE-VIII AND TYPE-X. Blood. A243-A243. 1994
- THE DEVELOPMENT AND EVALUATION OF A NOVEL TEST FOR HEPARIN-INDUCED THROMBOCYTOPENIA. Blood. A188-A188. 1994
- THE EFFECT OF GAMMA-IRRADIATION ON INTERLEUKIN-1-BETA (IL-1-BETA) AND INTERLEUKIN-6 (IL-6) ACCUMULATION DURING PLATELET CONCENTRATE STORAGE. Blood. A462-A462. 1994
- THE ROLE OF PLATELET ALLOANTIGEN GENOTYPING AND VNTR ANALYSIS USING DNA-DERIVED FROM AMNIOTIC-FLUID IN THE MANAGEMENT OF NEONATAL ALLOIMMUNE THROMBOCYTOPENIA. Blood. A527-A527. 1994
- BIOCHEMICAL-CHARACTERIZATION OF THE GOV ALLOANTIGEN ON HUMAN PLATELETS AND CELL-LINES. Blood. A269-A269. 1993
- CHARACTERIZATION OF MULTIMERIN EXPRESSION ON PLATELETS ACTIVATED IN-VITRO AND IN-VIVO. Blood. A158-A158. 1993
- CIRCULATING PLATELET-DERIVED MICROPARTICLES IN PATIENTS WITH HEPARIN-INDUCED THROMBOCYTOPENIA. Blood. A335-A335. 1993
- EFFICACY OF ANTI-D TO IMPROVE PLATELET TRANSFUSION RESPONSE - A RANDOMIZED TRIAL. Blood. A403-A403. 1993
- IGG FROM PATIENTS WITH HEPARIN-INDUCED THROMBOCYTOPENIA (HIT) BINDS TO A PF4/HEPARIN COMPLEX AND NOT TO HEPARIN ALONE. Blood. A335-A335. 1993
- PLATELET REACTIONS CAUSED PRIMARILY BY PLASMA SUPERNATANT. Transfusion. S62-S62. 1993
- HEPARIN-INDUCED THROMBOCYTOPENIA IS MORE COMMON WITH UNFRACTIONATED HEPARIN THAN WITH LOW-MOLECULAR-WEIGHT HEPARIN. Thrombosis and Haemostasis. 911-911. 1993
- PLATELET-DERIVED MICROPARTICLES ARE FOUND IN-VIVO IN PATIENTS WITH HEPARIN-INDUCED THROMBOCYTOPENIA (HIT). Thrombosis and Haemostasis. 912-912. 1993
- MULTIMERIN IS CONTAINED WITHIN THE GAMMA-GRANULES OF RESTING PLATELETS AND REDISTRIBUTES TO THE SURFACE-CONNECTED CANNALICULAR SYSTEM AND PLASMA-MEMBRANE FOLLOWING ACTIVATION. Clinical Research. A171-A171. 1992
- DETERMINANTS OF PLATELET DONOR VARIABILITY IN DIAGNOSTIC TESTING FOR HEPARIN-INDUCED THROMBOCYTOPENIA. Thrombosis and Haemostasis. 1036-1036. 1991
- Immune haemolytic anaemia and thrombocytopenia: drugs and autoantibodies. Biochemical Society Transactions. 183-186. 1991
- PLASMA-EXCHANGE IN TTP. Artificial Organs. 364-364. 1988
- HEPARIN-INDUCED THROMBOCYTOPENIA AND THROMBOTIC THROMBOCYTOPENIC PURPURA - DESTRUCTIVE THROMBOCYTOPENIC DISORDERS CHARACTERIZED BY ACUTE ARTERIAL THROMBOSIS. Seminars in Thrombosis and Hemostasis. 237-237. 1987
- PLATELET-AGGREGATION IN THROMBOTIC THROMBOCYTOPENIC PURPURA (TTP) IS CAUSED BY A CALCIUM-DEPENDENT CYSTEINE PROTEASE. Clinical and Investigative Medicine. B82-B82. 1987
- STUDY ON THE ETIOLOGY OF THROMBOCYTOPENIA IN PREECLAMPTIC TOXEMIA. Hypertension in Pregnancy. 191-191. 1987
- PLASMA GLYCOCALICIN DIFFERENTIATES THROMBOCYTOPENIA DUE TO DECREASED PRODUCTION FROM THROMBOCYTOPENIA DUE TO INCREASED DESTRUCTION. Clinical Research. A874-A874. 1986
- 895 CLINICAL IMPACT OF NEONATAL THROMBOCYTOPENIA–A PROSPECTIVE ONE YEAR STUDY. Pediatric Research. 260A-260A. 1985
- HYPERGAMMAGLOBULINEMIA CAN BE ASSOCIATED WITH A POSITIVE DIRECT ANTIGLOBULIN-TEST, A NON-REACTIVE ELUATE, AND NO EVIDENCE OF HEMOLYSIS. Transfusion. 451-451. 1985
- STUDIES ON THE DIAGNOSIS AND PATHO-PHYSIOLOGY OF HEPARIN-INDUCED THROMBOCYTOPENIA. Thrombosis and Haemostasis. 310-310. 1985
- NEUTROPHILS DO NOT CARRY ABO BLOOD-GROUP ANTIGENS ON THEIR SURFACE. Clinical Research. A311-A311. 1984
- SERUM IGG IS THE MAJOR INVIVO DETERMINANT OF CLEARANCE OF IGG-SENSITIZED ERYTHROCYTES. Clinical Research. A350-A350. 1984
- MUCH OF THE IGG ON RED-CELLS FROM PATIENTS WITH AUTOIMMUNE HEMOLYSIS IS NOT PATHOLOGICAL IGG. Clinical Research. A315-A315. 1983
- THE BIOLOGICAL RELEVANCE OF PLATELET-ASSOCIATED IGG. Thrombosis and Haemostasis. 331-331. 1983
- THE MECHANISM OF MALARIA-INDUCED IMMUNE THROMBOCYTOPENIA. Transfusion. 403-403. 1982
- THE MECHANISM OF MALARIA-INDUCED THROMBOCYTOPENIA. Clinical Research. A320-A320. 1982
- THE PRETREATMENT IDENTIFICATION OF THOSE PATIENTS WITH IDIOPATHIC THROMBOCYTOPENIC PURPURA WHO RESPOND TO PLASMAPHERESIS. Clinical Research. A320-A320. 1982
- ABNORMALITIES IN PLATELET ARACHIDONIC-ACID METABOLISM IN CHRONIC IDIOPATHIC THROMBOCYTOPENIC PURPURA. Thrombosis and Haemostasis. 97-97. 1981
- ABNORMALITIES IN PLATELET ARACHIDONIC-ACID METABOLISM IN CHRONIC IDIOPATHIC THROMBOCYTOPENIC PURPURA. Clinical Research. A349-A349. 1981
- Abnormalities In Platelet Arachidonic Acid Metabolism In Chronic Idiopathic Thrombocytopenic Purpura. Thrombosis and Haemostasis. 097-097. 1981
- HEPARIN ASSOCIATED THROMBOCYTOPENIA IS NOT A TYPICAL DRUG-INDUCED THROMBOCYTOPENIA. Clinical Research. A337-A337. 1981
- Heparin Associated Thrombocytopenia Is Not A Typical Drug Induced Thrombocytopenia. Thrombosis and Haemostasis. 215-215. 1981
- MEASUREMENT OF PLATELET-ASSOCIATED IGG IS OF LIMITED USEFULNESS IN THE DIAGNOSIS OF IDIOPATHIC THROMBOCYTOPENIC PURPURA. Transfusion. 616-616. 1981
- THE CLEARANCE OF SENESCENT PLATELETS MAY BE MEDIATED THROUGH THE BINDING OF IGG TO THEIR SURFACE. Clinical Research. A337-A337. 1981
- THE PRENATAL PREDICTION OF INFANT PLATELET COUNT IN MOTHERS WITH SUSPECTED AUTOIMMUNE THROMBOCYTOPENIA. Transfusion. 640-640. 1981
- THE PRODUCTION OF PLATELET CONTROLS FOR ASSAYS QUANTITATING PLATELET-ASSOCIATED IGG (PAIGG). Transfusion. 616-616. 1981
- DEVELOPMENT AND ASSESSMENT OF AN I125 ANTI-IGG ANTIGLOBULIN CONSUMPTION ASSAY FOR MEASURING PLATELET ASSOCIATED IGG (PAIGG). Transfusion. 643-643. 1980
- PLASMAPHERESIS IS EFFECTIVE IN THROMBOTIC THROMBOCYTOPENIA PURPURA (TTP) BY ALTERING THE BINDING CHARACTERISTICS OF IMMUNE-COMPLEXES. Circulation. 105-105. 1980
- SEX-RELATED DIFFERENCES IN PLATELET-FUNCTION INVIVO FOLLOWING ASPIRIN ADMINISTRATION. Circulation. 342-342. 1980
- SEX-RELATED DIFFERENCES IN THE EFFECTS OF ASPIRIN ON HEMOSTATIC PLUG FORMATION INVIVO. Clinical Research. A315-A315. 1980
- THE AMOUNT OF BLOOD-GROUP A-ANTIGEN, B-ANTIGEN ON PLATELETS IS PROPORTIONAL TO THE AMOUNT THAT IS FREE IN THE PLASMA. Transfusion. 625-625. 1980
- THE DETECTION OF DRUG-INDUCED THROMBOCYTOPENIA. Clinical Research. A316-A316. 1980
- THE MAJORITY OF PLATELET ASSOCIATED IGG (PAIGG) IS IN THE INTERIOR OF PLATELETS AND NOT MEASURABLE USING STANDARD ASSAYS. Transfusion. 625-626. 1980
- THE RELATIONSHIP BETWEEN THE HEMORRHAGIC AND ANTI-THROMBOTIC EFFECTS OF STANDARD AND LOW-MOLECULAR WEIGHT (LMW) HEPARINS. Circulation. 51-51. 1980
- Thrombotic Thrombocytopenic Purpura: Mechanism for Effectiveness of Plasmapheresis. Thrombosis and Haemostasis. 115-115. 1979
- A Comparison of Two Assays for Platelet Antibodies. Thrombosis and Haemostasis. 47-47. 1979
- THROMBOTIC THROMBOCYTOPENIC PURPURA - MECHANISM FOR EFFECTIVENESS OF PLASMAPHORESIS. Clinical Research. A299-A299. 1979
- Thrombotic Thrombocytopenic Purpura: Mechanism for Effectiveness of Plasmapheresis. Thrombosis and Haemostasis. 115-115. 1979
- THROMBOGENIC EFFECT OF HIGH DOSE ASPIRIN IN INJURY INDUCED EXPERIMENTAL VENOUS THROMBOSIS. Clinical Research. A350-A350. 1978
- PERITONEAL FLUID - MODEL FOR STUDYING BINDING OF SMALL MOLECULES TO SERUM-PROTEINS INVIVO. Clinical Research. A438-A438. 1977
- RAPID METHOD FOR DIAGNOSIS OF ACUTE URIC-ACID NEPHROPATHY. Clinical Research. A404-A404. 1976
journal articles
- Treatment of Critical Bleeds in Patients With Immune Thrombocytopenia: A Systematic Review.. European Journal of Haematology. 114:458-468. 2025
- Bleeding self‐assessments by patients with immune thrombocytopenia (ITP): An agreement study. American Journal of Hematology. 99:1184-1186. 2024
- Anti-platelet factor 4 antibody class and subclass in patients with vaccine-induced immune thrombocytopenia and thrombosis. Journal of Thrombosis and Haemostasis. 23:1077-1084. 2024
- Evaluation of laboratory testing parameters for vaccine-induced immune thrombotic thrombocytopenia and their implications for diagnosis. Journal of Thrombosis and Haemostasis. 22:304-306. 2024
- Prevalence and significance of large granular lymphocytes in patients with immune thrombocytopenia. Platelets. 34:2144194. 2023
- Antibodies against platelet factor 4 and the risk of cerebral venous sinus thrombosis in patients with vaccine-induced immune thrombotic thrombocytopenia. Journal of Thrombosis and Haemostasis. 21:2833-2843. 2023
- Investigation of anti-PF4 versus anti-PF4/heparin reactivity using fluid-phase enzyme immunoassay for 4 anti-PF4 disorders: classic heparin-induced thrombocytopenia (HIT), autoimmune HIT, vaccine-induced immune thrombotic thrombocytopenia, and spontaneous HIT. Journal of Thrombosis and Haemostasis. 21:2268-2276. 2023
- Adjudicating the Diagnosis of Immune Thrombocytopenia in a Clinical Research Study. TH Open. 07:e105-e109. 2023
- Adjudicating the Diagnosis of Immune Thrombocytopenia in a Clinical Research Study. TH Open. 07:e105-e109. 2023
- Characteristics of VITT antibodies in patients vaccinated with Ad26.COV2.S. Blood Advances. 7:246-250. 2023
- Longitudinal Characteristics of Anti-Platelet Factor 4 Immunoglobulin G in Vaccine-Induced Immune Thrombotic Thrombocytopenia. Blood. 140:5640-5641. 2022
- Clinical and laboratory predictors of fetal and neonatal alloimmune thrombocytopenia. Transfusion. 62:2213-2222. 2022
- Continuing Medical Education. Transfusion. 62:2212-2212. 2022
- The clinical and laboratory diagnosis of vaccine-induced immune thrombotic thrombocytopenia. Blood Advances. 6:4228-4235. 2022
- SARS-CoV-2 spike-dependent platelet activation in COVID-19 vaccine-induced thrombocytopenia. Blood Advances. 6:2250-2253. 2022
- Lessons from vaccine-induced immune thrombotic thrombocytopenia. Nature Reviews Immunology. 21:753-755. 2021
- Platelet variability index: a measure of platelet count fluctuations in patients with immune thrombocytopenia. Blood Advances. 5:4256-4264. 2021
- Antibody epitopes in vaccine-induced immune thrombotic thrombocytopaenia. Nature. 596:565-569. 2021
- Adjunct Immune Globulin for Vaccine-Induced Immune Thrombotic Thrombocytopenia. New England Journal of Medicine. 385:720-728. 2021
- Definition of a critical bleed in patients with immune thrombocytopenia: Communication from the ISTH SSC Subcommittee on Platelet Immunology. Journal of Thrombosis and Haemostasis. 19:2082-2088. 2021
- Performance characteristics of platelet autoantibody testing for the diagnosis of immune thrombocytopenia using strict clinical criteria. British Journal of Haematology. 194:439-443. 2021
- Heparin-induced thrombocytopenia. CANADIAN MEDICAL ASSOCIATION JOURNAL. 193:E736-E736. 2021
- Platelet‐activating immune complexes identified in critically ill COVID‐19 patients suspected of heparin‐induced thrombocytopenia. Journal of Thrombosis and Haemostasis. 19:1342-1347. 2021
- Characteristics of Anti-SARS-CoV-2 Antibodies in Recovered COVID-19 Subjects. Viruses. 13:697-697. 2021
- A comparative study of platelet factor 4‐enhanced platelet activation assays for the diagnosis of heparin‐induced thrombocytopenia. Journal of Thrombosis and Haemostasis. 19:1096-1102. 2021
- Platelet Activating Immune Complexes Identified in COVID-19 Associated Coagulopathy 2020
- The role of fluid-phase immune complexes in the pathogenesis of heparin-induced thrombocytopenia. Thrombosis Research. 194:135-141. 2020
- Perioperative oral eltrombopag versus intravenous immunoglobulin in patients with immune thrombocytopenia: a non-inferiority, multicentre, randomised trial. The Lancet Haematology. 7:e640-e648. 2020
- Platelet autoantibodies in the bone marrow of patients with immune thrombocytopenia. Blood Advances. 4:2962-2966. 2020
- Increased cytotoxic potential of CD8⁺T cells in immune thrombocytopenia. British Journal of Haematology. 188:e72-e76. 2020
- Serotonin‐release assay‐negative heparin‐induced thrombocytopenia. American Journal of Hematology. 95:38-47. 2020
- A platelet viability assay (PVA) for the diagnosis of heparin-induced thrombocytopenia. Platelets. 30:1017-1021. 2019
- Corrigendum. Journal of Thrombosis and Haemostasis. 17:1578-1578. 2019
- The sensitivity and specificity of platelet autoantibody testing in immune thrombocytopenia: a systematic review and meta‐analysis of a diagnostic test. Journal of Thrombosis and Haemostasis. 17:787-794. 2019
- Peri-Operative Eltrombopag or Immune Globulin for Patients with Immune Thrombocytopaenia (The Bridging ITP Trial): Methods and Rationale. Thrombosis and Haemostasis. 119:500-507. 2019
- Characterization of platelet factor 4 amino acids that bind pathogenic antibodies in heparin‐induced thrombocytopenia. Journal of Thrombosis and Haemostasis. 17:389-399. 2019
- Managing antithrombotic therapy in immune thrombocytopenia: development of the TH2 risk assessment score. Blood. 132:2684-2686. 2018
- How do we diagnose immune thrombocytopenia in 2018?. Hematology. American Society of Hematology. Education Program. 2018:561-567. 2018
- Fluid-Phase Immune Complexes Can Assemble and Activate Platelets in Heparin-Induced Thrombocytopenia. Blood. 132:3746-3746. 2018
- Megakaryocyte apoptosis in immune thrombocytopenia. Platelets. 29:729-732. 2018
- Cellular immune responses to platelet factor 4 and heparin complexes in patients with heparin‐induced thrombocytopenia. Journal of Thrombosis and Haemostasis. 16:1402-1412. 2018
- Platelet-Activating Antibodies Are Detectable at the Earliest Onset of Heparin-Induced Thrombocytopenia, With Implications for the Operating Characteristics of the Serotonin-Release Assay. Chest. 153:1396-1404. 2018
- The Use of Anticoagulation in Patients With Thrombocytopenia. Blood. 15. 2018
- Development of a high-yield expression and purification system for platelet factor 4. Platelets. 29:249-256. 2018
- Misdiagnosis of primary immune thrombocytopenia and frequency of bleeding: lessons from the McMaster ITP Registry. Blood Advances. 1:2414-2420. 2017
- The effect of rituximab on anti‐platelet autoantibody levels in patients with immune thrombocytopenia. British Journal of Haematology. 178:302-307. 2017
- High-dose dexamethasone compared with prednisone for previously untreated primary immune thrombocytopenia: a systematic review and meta-analysis. The Lancet Haematology. 3:e489-e496. 2016
- Difficulties in establishing the diagnosis of immune thrombocytopenia: An agreement study. American Journal of Hematology. 91:E327-E329. 2016
- Producing megakaryocytes from a human peripheral blood source. Transfusion. 56:1066-1074. 2016
- Effect of a thrombopoietin receptor agonist on use of intravenous immune globulin in patients with immune thrombocytopenia. Transfusion. 56:73-79. 2016
- Antibody binding to megakaryocytes in vivo in patients with immune thrombocytopenia. European Journal of Haematology. 95:532-537. 2015
- Distinguishing between anti–platelet factor 4/heparin antibodies that can and cannot cause heparin‐induced thrombocytopenia. Journal of Thrombosis and Haemostasis. 13:1900-1907. 2015
- A phase‐II sequential case‐series study of all patients presenting to four plasma exchange centres with presumed relapsed/refractory thrombotic thrombocytopenic purpura treated with rituximab. British Journal of Haematology. 170:208-217. 2015
- Pitfalls in the diagnosis of heparin‐Induced thrombocytopenia: A 6‐year experience from a reference laboratory. American Journal of Hematology. 90:629-633. 2015
- The platelet serotonin‐release assay. American Journal of Hematology. 90:564-572. 2015
- Severe bleeding events in adults and children with primary immune thrombocytopenia: a systematic review. Journal of Thrombosis and Haemostasis. 13:457-464. 2015
- Rituximab plus standard of care for treatment of primary immune thrombocytopenia: a systematic review and meta-analysis. The Lancet Haematology. 2:e75-e81. 2015
- Low Level Platelet-Activating Antibodies in Patients Suspected of Having Heparin-Induced Thrombocytopenia but Testing Negative in the ”Gold Standard” Functional Test. Blood. 124:2757-2757. 2014
- Novel treatments for immune thrombocytopenia. Presse Medicale. 43:e87-e95. 2014
- Sustained remissions of immune thrombocytopenia associated with the use of thrombopoietin receptor agonists. Transfusion. 53:2807-2812. 2013
- The effect of rituximab on vaccine responses in patients with immune thrombocytopenia. Blood. 122:1946-1953. 2013
- Approach to the Diagnosis and Management of Drug-Induced Immune Thrombocytopenia. Transfusion Medicine Reviews. 27:137-145. 2013
- FcγRIIa proteolysis as a diagnostic biomarker for heparin-induced thrombocytopenia. Journal of Thrombosis and Haemostasis. 11:1146-1153. 2013
- Nonheparin Anticoagulants for Heparin-Induced Thrombocytopenia. New England Journal of Medicine. 368:737-744. 2013
- A blinded study of bone marrow examinations in patients with primary immune thrombocytopenia. European Journal of Haematology. 90:121-126. 2013
- A systematic evaluation of laboratory testing for drug‐induced immune thrombocytopenia. Journal of Thrombosis and Haemostasis. 11:169-176. 2013
- Rituximab maintenance for relapsed refractory thrombotic thrombocytopenic purpura. Transfusion. 52:2517-2523. 2012
- A prospective study measuring the development of antibodies against platelet factor 4–heparin in healthy males after exposure to heparins. Journal of Thrombosis and Haemostasis. 10:1446-1449. 2012
- A pilot randomized trial of adjuvant rituximab or placebo for nonsplenectomized patients with immune thrombocytopenia. Blood. 119:1356-1362. 2012
- Bone Marrow Specimens From Patients with Immune Thrombocytopenia (ITP) Demonstrate Increased Megakaryocyte-Bound IgG and Increased T-Helper Cells. Blood. 118:2233-2233. 2011
- Identifying Drugs Implicated in Drug-Induced Immune Thrombocytopenia Using Levels of Evidence Applied to Laboratory Tests,. Blood. 118:3304-3304. 2011
- Prevalence and Risk of Preexisting Heparin-Induced Thrombocytopenia Antibodies in Patients With Acute VTE. Chest. 140:366-373. 2011
- The association between platelet activation and FcγRIIa proteolysis. Journal of Thrombosis and Haemostasis. 9:885-887. 2011
- Misleading hepatitis B test results due to intravenous immunoglobulin administration: implications for a clinical trial of rituximab in immune thrombocytopenia. Transfusion. 50:2577-2581. 2010
- The Utility of Bone Marrow Examinations for the Diagnosis of Immune Thrombocytopenia.. Blood. 116:3691-3691. 2010
- Understanding Treatment Preferences In Patients with Primary Immune Thrombocytopenia Contemplating Splenectomy: A Qualitative Study. Blood. 116:392-392. 2010
- Combination immunosuppressant therapy for patients with chronic refractory immune thrombocytopenic purpura. Blood. 115:29-31. 2010
- The use of well‐characterized sera for the assessment of new diagnostic enzyme‐immunoassays for the diagnosis of heparin‐induced thrombocytopenia. Journal of Thrombosis and Haemostasis. 8:216-218. 2010
- Passive Transfer of Hepatitis B Core Antibody by Intravenous Immune Globulin in Patients with Immune Thrombocytopenic Purpura.. Blood. 114:2418-2418. 2009
- Spectral Analysis of Platelet Oscillations in Cyclic Thrombocytopenia.. Blood. 114:4459-4459. 2009
- New treatments for idiopathic thrombocytopenic purpura: rethinking old hypotheses. Expert Opinion on Investigational Drugs. 18:805-819. 2009
- Platelet count response to H. pylori treatment in patients with immune thrombocytopenic purpura with and without H. pylori infection: a systematic review. Haematologica. 94:850-856. 2009
- Studies of the immune response in heparin-induced thrombocytopenia. Blood. 113:4963-4969. 2009
- Autoantibodies in Patients with ITP Do Not Bind to Patient-Specific Epitopes on Platelet Glycoproteins.. Blood. 112:3427-3427. 2008
- The Efficacy of H. pylori Eradication Therapy in H. pylori-Infected and Uninfected Patients with Immune Thrombocytopenic Purpura: A Systematic Review.. Blood. 112:3413-3413. 2008
- Diagnosis and Management of Neonatal Alloimmune Thrombocytopenia. Transfusion Medicine Reviews. 22:255-267. 2008
- Heparin-induced thrombocytopenia: a historical perspective. Blood. 112:2607-2616. 2008
- An algorithm for resolving ‘indeterminate’ test results in the platelet serotonin release assay for investigation of heparin‐induced thrombocytopenia. Journal of Thrombosis and Haemostasis. 6:1595-1597. 2008
- Predictors of clinical outcome in patients with heparin-induced thrombocytopenia treated with direct thrombin inhibition. Blood Coagulation and Fibrinolysis. 19:471-475. 2008
- Quantitative interpretation of optical density measurements using PF4‐dependent enzyme‐immunoassays. Journal of Thrombosis and Haemostasis. 6:1304-1312. 2008
- A Spontaneous Prothrombotic Disorder Resembling Heparin-induced Thrombocytopenia. American Journal of Medicine. 121:632-636. 2008
- Increased mortality in hemodialysis patients having specific antibodies to the platelet factor 4-heparin complex. Kidney International. 73:213-219. 2008
- An Individual Platelet Count Set-Point in ITP: A Concept Learned from Patients with Mild Thrombocytopenia and a Good Response to IVIg or Corticosteroids.. Blood. 110:3926-3926. 2007
- Current Options for the Treatment of Idiopathic Thrombocytopenic Purpura. Seminars in Hematology. 44:S12-S23. 2007
- Intravenous immunoglobulin as an adjunct to plasma exchange for the treatment of chronic thrombotic thrombocytopenic purpura. Vox Sanguinis. 93:173-175. 2007
- Testing for heparin‐induced thrombocytopenia: are we there yet?. Journal of Thrombosis and Haemostasis. 5:1371-1372. 2007
- Systematic Review: Efficacy and Safety of Rituximab for Adults with Idiopathic Thrombocytopenic Purpura. ACP journal club. 146:25-25. 2007
- An Algorithm for “Indeterminate” Test Results in the Platelet Serotonin Release Assay for Heparin-Induced Thrombocytopenia (HIT).. Blood. 108:1048-1048. 2006
- Platelet-Activating Anti-Platelet Factor 4/Polyanion Antibodies without Preceding Heparin Therapy: A Transient Autoimmune Disorder Resembling Heparin-Induced Thrombocytopenia (“Spontaneous HIT”).. Blood. 108:1047-1047. 2006
- Thromboembolic complications of malignancy: Part 1: Risk. Commentary. Oncology. 19:1084-1088. 2005
- Anti–platelet factor 4/heparin antibodies in orthopedic surgery patients receiving antithrombotic prophylaxis with fondaparinux or enoxaparin. Blood. 106:3791-3796. 2005
- Laboratory testing for the antibodies that cause heparin-induced thrombocytopenia: How much class do we need?. Translational Research. 146:341-346. 2005
- A Revisit of the Criteria To Define Remission in Patients with Idiopathic Thrombocytopenia Undergoing Splenectomy.. Blood. 106:3020-3020. 2005
- Intravenous gamma Globulin Does Not Increase RNA Expression of FcgRIIb in Purified Human Monocytes.. Blood. 106:3888-3888. 2005
- Mechanisms of Static and Shear-Induced Platelet Adhesion: Differences in the Adhesion Supported by MMRN1 Comparisons with Other β3 Integrin Ligands.. Blood. 106:2659-2659. 2005
- Rituximab for the Treatment of Adults with ITP: A Systematic Review.. Blood. 106:1241-1241. 2005
- Heparin-Induced Thrombocytopenia: An Iceberg Rising. Mayo Clinic proceedings. 80:988-990. 2005
- Thrombo-embolic complications of malignancy - Part 2: Management - The Linenberger/Wittkowsky article reviewed. Oncology. 19:1087-1088. 2005
- Assessing the effectiveness of whole blood–derived platelets stored as a pool: a randomized block noninferiority trial. Transfusion. 45:896-903. 2005
- In vitro evaluation of prestorage pooled leukoreduced whole blood–derived platelets stored for up to 7 days. Transfusion. 45:904-910. 2005
- Heparin-Induced Skin Lesions and Other Unusual Sequelae of the Heparin-Induced Thrombocytopenia Syndrome. Chest. 127:1857-1861. 2005
- The Pathophysiology of Heparin-Induced Thrombocytopenia. Chest. 127:9S-20S. 2005
- Analyses of cellular multimerin 1 receptors: in vitro evidence of binding mediated by αΙΙbβ3 and αvβ3. Thrombosis and Haemostasis. 94:1004-1011. 2005
- Argatroban anticoagulation in patients with a history of heparin-induced thrombocytopenia. Thrombosis Research. 116:121-126. 2005
- Effect of fondaparinux on platelet activation in the presence of heparin-dependent antibodies: a blinded comparative multicenter study with unfractionated heparin. Blood. 105:139-144. 2005
- Dissociation between the level of von Willebrand factor‐cleaving protease activity and disease in a patient with congenital thrombotic thrombocytopenic purpura. American Journal of Hematology. 77:387-390. 2004
- Laboratory Testing for Hit Antibodies: How Much Class Do We Need?.. Blood. 104:3022-3022. 2004
- Treatment of Heparin-Induced Thrombocytopenia. JAMA Internal Medicine. 164:361-361. 2004
- IGIV-C, a novel intravenous immunoglobulin: evaluation of safety, efficacy, mechanisms of action, and impact on quality of life. Thrombosis and Haemostasis. 91:771-778. 2004
- A retrospective 11-year analysis of obstetric patients with idiopathic thrombocytopenic purpura. Blood. 102:4306-4311. 2003
- An Improved Definition of Immune Heparin-Induced Thrombocytopenia in Postoperative Orthopedic Patients. JAMA Internal Medicine. 163:2518-2518. 2003
- The IgG subclasses of platelet‐associated autoantibodies directed against platelet glycoproteins IIb/IIIa in patients with idiopathic thrombocytopenic purpura. British Journal of Haematology. 122:818-824. 2003
- Argatroban Anticoagulation in Patients With Heparin-Induced Thrombocytopenia. JAMA Internal Medicine. 163:1849-1849. 2003
- Inhibition of Microsurgical Thrombosis by the Platelet Glycoprotein IIb/IIIa Antagonist SR121566A. Plastic and Reconstructive Surgery. 112:177-185. 2003
- Frequency of Heparin‐Induced Thrombocytopenia in Critical Care Patients. Pharmacotherapy. 23:745-753. 2003
- Congenital Thrombophilic States Associated with Venous Thrombosis: A Qualitative Overview and Proposed Classification System. ACP journal club. 138:128-128. 2003
- Reply. Transfusion. 42:1524-1525. 2002
- The mechanism of action of high-dose IgG in idiopathic thrombocytopenic purpura. Blood. 100:1933-1934. 2002
- A review of randomized controlled trials using therapeutic apheresis*. Transfusion Medicine Reviews. 16:200-229. 2002
- Platelet transfusions in children: results of a randomized, prospective, crossover trial of plasma removal and a prospective audit of WBC reduction. Transfusion. 42:753-758. 2002
- Thrombotic thrombocytopenic purpura and hemolytic uremic syndrome: will recent insight into pathogenesis translate into better treatment?. Transfusion. 42:388-392. 2002
- Heparin-induced thrombocytopenia: an overview. Blood Reviews. 16:77-80. 2002
- Heparin-induced thrombocytopenia: an overview. Blood Reviews. 16:77-80. 2002
- Idiopathic thrombocytopenic purpura complicating pregnancy. Blood Reviews. 16:43-46. 2002
- Idiopathic thrombocytopenic purpura complicating pregnancy. Blood Reviews. 16:43-46. 2002
- Argatroban - A novel thrombin-specific inhibitor for the treatment of heparin-induced thrombocytopenia. Today's Therapeutic Trends. 20:15-35. 2002
- Delayed-Onset Heparin-Induced Thrombocytopenia and Thrombosis. ACP journal club. 135:502-502. 2001
- Decreased von Willebrand factor protease activity associated with thrombocytopenic disorders. Blood. 98:1842-1846. 2001
- Heparin-Induced Thrombocytopenia. New England Journal of Medicine. 345:619-620. 2001
- Treatment of adults with ITP: less may be more. Blood. 97:2533-2533. 2001
- Temporal Aspects of Heparin-Induced Thrombocytopenia. New England Journal of Medicine. 344:1286-1292. 2001
- Argatroban Anticoagulant Therapy in Patients With Heparin-Induced Thrombocytopenia. Circulation. 103:1838-1843. 2001
- A prospective cross-sectional study to characterize selected autoimmune (AI) markers and report the incidence of antithrombopoietin antibodies (aTPO) in patients with immune thrombocytopenic purpura (ITP). Blood. 96. 2000
- Evaluation of platelet morphology and the subcellular distribution of PAIgG in patients with ITP and non-immune thrombocytopenia. Blood. 96. 2000
- Expression of cd109 with alternate forms of membrane anchoring unique to platelets and megakaryocytic cell lines. Blood. 96. 2000
- Possible pathways of IGG trafficking in platelets. Blood. 96. 2000
- The impact of idiopathic thrombocytopenic purpura in pregnancy. Blood. 96. 2000
- Treatment of chronic refractory idiopathic thrombocytopenic purpura with cyclophosphamide and cyclosporine. Blood. 96. 2000
- Impact of the patient population on the risk for heparin-induced thrombocytopenia. Blood. 96:1703-1708. 2000
- Idiopathic immune thrombocytopenic purpura: An update. Seminars in Hematology. 37:219-221. 2000
- Management of idiopathic thrombocytopenic purpura in pregnancy. Seminars in Hematology. 37:275-289. 2000
- Morphological analysis of microparticle generation in heparin-induced thrombocytopenia. Blood. 96:188-194. 2000
- Morphological analysis of microparticle generation in heparin-induced thrombocytopenia. Blood. 96:188-194. 2000
- The use of electron microscopy in the investigation of the ultrastructural morphology of immune thrombocytopenic purpura platelets. Seminars in Hematology. 37:222-228. 2000
- The use of electron microscopy in the investigation of the ultrastructural morphology of immune thrombocytopenic purpura platelets. Seminars in Hematology. 37:222-228. 2000
- The essential role of basic science in medical education: the perspective from psychology - Discussion. Clinical and Investigative Medicine. 23:52-54. 2000
- Where we want to be by 2010 - Closing remarks. Clinical and Investigative Medicine. 23:64-66. 2000
- Where we want to be by 2010 - Closing remarks - Discussion. Clinical and Investigative Medicine. 23:67-69. 2000
- Closing remarks. Clinical and Investigative Medicine. 23:64-66. 2000
- Discussion. Clinical and Investigative Medicine. 23:67-69. 2000
- Investigation of a platelet factor 4 polymorphism on the immune response in patients with heparin-induced thrombocytopenia. Platelets. 11:23-27. 2000
- Alloimmune Thrombocytopenia after Organ Transplantation. New England Journal of Medicine. 341:1504-1507. 1999
- Calpain activity in bone marrow transplant-associated thrombotic thrombocytopenic purpura. Bone Marrow Transplantation. 24:641-645. 1999
- Measurement of endogenous and exogenous alpha‐granular platelet proteins in patients with immune and nonimmune thrombocytopenia. British Journal of Haematology. 106:762-770. 1999
- Gestational Thrombocytopenia. Clinical Obstetrics and Gynecology. 42:327-334. 1999
- RhD status of a fetus at risk for haemolytic disease with a discrepant maternal DNA-based RhD genotype. Prenatal Diagnosis. 19:424-427. 1999
- A prospective study of protein‐specific assays used to investigate idiopathic thrombocytopenic purpura. British Journal of Haematology. 104:442-447. 1999
- Serum-induced platelet procoagulant activity: An assay for the characterization of prothrombotic disorders. Translational Research. 133:129-133. 1999
- The clinical management of heparin-induced thrombocytopenia.. Seminars in Hematology. 36:17-21. 1999
- The interaction of ancrod with human platelets. Platelets. 10:24-29. 1999
- Laboratory abnormalities in thrombotic thrombocytopenic purpura. British Journal of Haematology. 103:1031-1036. 1998
- Laboratory abnormalities in thrombotic thrombocytopenic purpura. Canadian Apheresis Group.. British Journal of Haematology. 103:1031-1036. 1998
- ABH antigens on human platelets: Expression on the glycosyl phosphatidylinositol-anchored protein CD109. Translational Research. 132:142-148. 1998
- Dealing with Drug-Induced Thrombocytopenia. Hospital Practice. 33:37-60. 1998
- Heparin-induced thrombocytopenia. Postgraduate Medicine. 103:169-178. 1998
- Factor V Leiden and Thrombotic Complications in Heparin-induced Thrombocytopenia. Thrombosis and Haemostasis. 79:50-53. 1998
- The Pathogenesis of Venous Limb Gangrene Associated with Heparin-Induced Thrombocytopenia. ACP journal club. 127:804-804. 1997
- High-Dose Intravenous Immune Globulin and the Response to Splenectomy in Patients with Idiopathic Thrombocytopenic Purpura. New England Journal of Medicine. 337:1087-1089. 1997
- High-dose intravenous immune globulin and the response to splenectomy in patients with idiopathic thrombocytopenic purpura - Reply. New England Journal of Medicine. 337:1089-1089. 1997
- Activation of platelets by sera containing igg1 heparin-dependent antibodies: an explanation for the predominance of the Fcγrlla “low responder” (his131) gene in patients with heparin-induced thrombocytopenia. Translational Research. 130:278-284. 1997
- Maternal immunization to Gov system alloantigens on human platelets. Transfusion. 37:823-828. 1997
- A Canadian hospital-based HIV/hepatitis C look-back notification program.. CANADIAN MEDICAL ASSOCIATION JOURNAL. 157:149-154. 1997
- PROTEOLYTIC DEGRADATION OF HIGH MOLECULAR WEIGHT KININOGEN IN ACUTE THROMBOTIC THROMBOCYTOPENIC PURPURA. British Journal of Haematology. 97:762-767. 1997
- Splenectomy for Relapsing Thrombotic Thrombocytopenic Purpura. ACP journal club. 126:915-915. 1997
- High-Dose Intravenous Immune Globulin and the Response to Splenectomy in Patients with Idiopathic Thrombocytopenic Purpura. New England Journal of Medicine. 336:1494-1498. 1997
- Failure of pulse high‐dose dexamethasone in chronic idiopathic immune thrombocytopenia. American Journal of Hematology. 54:267-270. 1997
- Immune Thrombocytopenic Purpura. Journal of Clinical Rheumatology. 3:95-101. 1997
- Acute idiopathic thrombocytopenic purpura - Management in childhood - Response. Blood. 89:1466-1466. 1997
- Acute idiopathic thrombocytopenic purpura--management in childhood.. Blood. 89:1465. 1997
- Diagnosis and Treatment of Idiopathic Thrombocytopenic Purpura: Recommendations of the American Society of Hematology. ACP journal club. 126:319-319. 1997
- Laboratory investigation of immune thrombocytopenia.. Journal of Clinical Pathology - Clinical Molecular Pathology. 50:5-12. 1997
- A diagnostic test for heparin‐induced thrombocytopenia: detection of platelet microparticles using flow cytometry. British Journal of Haematology. 95:724-731. 1996
- Diagnosis and treatment of idiopathic thrombocytopenic purpura. American Society of Hematology ITP Practice Guideline Panel.. American Family Physician. 54:2437-2452. 1996
- A 14-year study of heparin-induced thrombocytopenia. American Journal of Medicine. 101:502-507. 1996
- Heparin-induced thrombocytopenia: What the serologists have taught us. Translational Research. 128:346-348. 1996
- The epitope specificity of heparin‐induced thrombocytopenia. British Journal of Haematology. 95:161-167. 1996
- A simple and rapid competitive enzyme‐linked immunosorbent assay to identify HPA‐1a (Pl^A1)‐negative donor platelet units. Transfusion. 36:805-808. 1996
- Splenectomy Done during Hematologic Remission To Prevent Relapse in Patients with Thrombotic Thrombocytopenic Purpura. ACP journal club. 125:294-294. 1996
- Idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for the American Society of Hematology [see comments]. Blood. 88:3-40. 1996
- An autosomal dominant, qualitative platelet disorder associated with multimerin deficiency, abnormalities in platelet factor V, thrombospondin, von Willebrand factor, and fibrinogen and an epinephrine aggregation defect. Blood. 87:4967-4978. 1996
- Isolation and characterization of cysteine proteinase in thrombotic thrombocytopenic purpura. British Journal of Haematology. 93:421-426. 1996
- Thrombocytopenia in pregnancy: diagnosis, pathogenesis and management. Blood Reviews. 10:8-16. 1996
- A prospective study to determine the frequency and clinical significance of alloimmunization post‐transfusion. British Journal of Haematology. 91:1000-1005. 1995
- Diagnosis of Heparin-induced Thrombocytopenia:Still a Journey, Not Yet a Destination. American Journal of Clinical Pathology. 104:611-613. 1995
- The prenatal identification of fetal compatibility in neonatal alloimmune thrombocytopenia using amniotic fluid and variable number of tandem repeat (VNTR) analysis. British Journal of Haematology. 91:742-746. 1995
- Heparin-Induced Thrombocytopenia. New England Journal of Medicine. 333:1006-1007. 1995
- Characterization and localization of the Gova/b alloantigens to the glycosylphosphatidylinositol-anchored protein CDw109 on human platelets. Blood. 86:2807-2814. 1995
- Characterization and localization of the Gova/b alloantigens to the glycosylphosphatidylinositol-anchored protein CDw109 on human platelets. Blood. 86:2807-2814. 1995
- Perinatal Thrombocytopenia. Clinics in Perinatology. 22:779-801. 1995
- The Development of a Bacteriophage Expression Vector for Cloning Immunoglobulin Variable Region Genes from B‐Cell Genomic DNA^a. Annals of the New York Academy of Sciences. 764:580-582. 1995
- Hirulog in the Treatment of Unstable Angina. Circulation. 92:727-733. 1995
- Factor V Is Complexed with Multimerin in Resting Platelet Lysates and Colocalizes with Multimerin in Platelet α-Granules. Journal of Biological Chemistry. 270:19217-19224. 1995
- The cDNA Sequence of Human Endothelial Cell Multimerin. Journal of Biological Chemistry. 270:18246-18251. 1995
- Bacterial infection‐associated improvement of platelet counts in two patients with chronic and unresponsive idiopathic thrombocytopenic purpura with normal platelet survival studies. British Journal of Haematology. 90:332-335. 1995
- Three examples of Rh haemolytic disease of the newborn with a negative direct antiglobulin test. Transfusion Medicine. 5:113-116. 1995
- Heparin-Induced Thrombocytopenia in Patients Treated with Low-Molecular-Weight Heparin or Unfractionated Heparin. New England Journal of Medicine. 332:1330-1336. 1995
- Late Relapses in Patients Successfully Treated for Thrombotic Thrombocytopenic Purpura. ACP journal club. 122:569-569. 1995
- The Role of Plasma from Platelet Concentrates in Transfusion Reactions. Survey of Anesthesiology. 39:135-135. 1995
- Profound thrombocytopenia complicating dietary erucic acid therapy for adrenoleukodystrophy. American Journal of Hematology. 48:132-133. 1995
- Multimerin. Current Opinion in Hematology. 2:339-344. 1995
- Multimerin: A Multimeric Protein Stored in Platelet Alpha-granules. Platelets. 6:1-10. 1995
- The Serological Investigation of Patients with Autoimmune Thrombocytopenia. Thrombosis and Haemostasis. 74:228-233. 1995
- The use of anti‐D to improve post‐transfusion platelet response: a randomized trial. British Journal of Haematology. 89:163-168. 1995
- Sera from patients with heparin-induced thrombocytopenia generate platelet-derived microparticles with procoagulant activity: an explanation for the thrombotic complications of heparin-induced thrombocytopenia. Blood. 84:3691-3699. 1994
- The Role of the Plasma from Platelet Concentrates in Transfusion Reactions. New England Journal of Medicine. 331:625-628. 1994
- Immunoglobulin G from patients with heparin-induced thrombocytopenia binds to a complex of heparin and platelet factor 4. Blood. 83:3232-3239. 1994
- Immunoglobulin G from patients with heparin-induced thrombocytopenia binds to a complex of heparin and platelet factor 4. Blood. 83:3232-3239. 1994
- Fetal Thrombocytopenia and Its Relation to Maternal Thrombocytopenia. Obstetrical and Gynecological Survey. 49:240-241. 1994
- Fetal Thrombocytopenia and Its Relation to Maternal Thrombocytopenia. Survey of Anesthesiology. 38:117-117. 1994
- FETAL AND MATERNAL THROMBOCYTOPENIA - REPLY. New England Journal of Medicine. 330:941-941. 1994
- Fetal and Maternal Thrombocytopenia. New England Journal of Medicine. 330:940-941. 1994
- Heparin-induced skin necrosis. American Journal of Medicine. 95:662-663. 1993
- Pregnancy in Patients With Idiopathic Thrombocytopenic Purpura. Obstetrical and Gynecological Survey. 48:781-788. 1993
- Fetal Thrombocytopenia and Its Relation to Maternal Thrombocytopenia. New England Journal of Medicine. 329:1463-1466. 1993
- A prospective study to identify the risk factors associated with acute reactions to platelet and red cell transfusions. Transfusion. 33:794-797. 1993
- Development of residency program guidelines for interaction with the pharmaceutical industry. Education Council, Residency Training Programme in Internal Medicine, Department of Medicine, McMaster University, Hamilton, Ont.. CANADIAN MEDICAL ASSOCIATION JOURNAL. 149:405-408. 1993
- Monoclonal Antibodies Against Platelet Glycoproteins. Transfusion Medicine Reviews. 7:156-172. 1993
- TESTING FOR HIV - RESPONSE. Canadian Family Physician. 39:1555-1556. 1993
- Heparin‐induced thrombocytopenia and thrombosis: clinical and laboratory studies. British Journal of Haematology. 84:322-328. 1993
- Multimerin is found in the alpha-granules of resting platelets and is synthesized by a megakaryocytic cell line.. Journal of Clinical Investigation. 91:2630-2639. 1993
- Antibody-mediated platelet activation.. Translational Research. 121:382-384. 1993
- OMITTING THE ANTIGLOBULIN CROSS-MATCH. British Journal of Haematology. 83:522-523. 1993
- OMITTING THE ANTIGLOBULIN CROSSMATCH. British Journal of Haematology. 83:521-523. 1993
- Investigation of human platelet alloantigens and glycoproteins using non-radioactive immunoprecipitation. Journal of Immunological Methods. 158:77-85. 1993
- Frequent association of factor VII defects with other clotting disorders. Blood Coagulation and Fibrinolysis. 3:831-834. 1992
- Frequent association of factor VII defects with other clotting disorders. Blood Coagulation and Fibrinolysis. 3:829-830. 1992
- PATHOPHYSIOLOGY OF HEPARIN‐INDUCED THROMBOCYTOPENIA. British Journal of Haematology. 82:778-779. 1992
- Calpain activity in patients with thrombotic thrombocytopenic purpura is associated with platelet microparticles. Blood. 80:2246-2251. 1992
- Thrombotic thrombocytopenic purpura. Blood Coagulation and Fibrinolysis. 3:655-660. 1992
- Thrombotic thrombocytopenic purpura: outcome in 24 patients with renal impairment treated with plasma exchange. Transfusion. 32:710-714. 1992
- Determinants of donor platelet variability when testing for heparin-induced thrombocytopenia.. Translational Research. 120:371-379. 1992
- The production of human monoclonal antiplatelet auto‐antibodies derived from human lymphocytes of normal origin: reactivity to DNA, anionic phospholipids and platelet proteins. British Journal of Haematology. 82:99-106. 1992
- A novel congenital haemostatic defect. Blood Coagulation and Fibrinolysis. 3:357-360. 1992
- A novel congenital haemostatic defect. Blood Coagulation and Fibrinolysis. 3:357-360. 1992
- A prospective study to determine the safety of omitting the antiglobulin crossmatch from pretransfusion testing. British Journal of Haematology. 81:579-584. 1992
- HLA‐DR expression by platelets in acute idiopathic thrombocytopenic purpura. British Journal of Haematology. 81:552-557. 1992
- Splenic Radiation for Corticosteroid-resistant Immune Thrombocytopenia. ACP journal club. 116:977-981. 1992
- Thrombocytopenia caused by passive transfusion of anti-glycoprotein Ia/IIa alloantibody (anti-HPA-5b). Blood. 79:2480-2484. 1992
- Thrombocytopenia caused by passive transfusion of anti-glycoprotein Ia/IIa alloantibody (anti-HPA-5b). Blood. 79:2480-2484. 1992
- A human monoclonal autoantibody to platelet glycoprotein IIb derived from normal human lymphocytes. Blood. 79:447-451. 1992
- Comparison of Plasma Exchange With Plasma Infusion in the Treatment of Thrombotic Thrombocytopenia Purpura. Obstetrical and Gynecological Survey. 47:16-17. 1992
- Rabbit Platelets do not Express Fc Receptors for IgG. Platelets. 3:35-39. 1992
- Rapid anticoagulation using ancrod for heparin-induced thrombocytopenia [see comments]. Blood. 78:2194-2197. 1991
- Rapid anticoagulation using ancrod for heparin-induced thrombocytopenia [see comments]. Blood. 78:2194-2197. 1991
- Investigation of the mechanisms of monoclonal antibody-induced platelet activation. Blood. 78:1019-1026. 1991
- Comparison of Plasma Exchange with Plasma Infusion in the Treatment of Thrombotic Thrombocytopenic Purpura. New England Journal of Medicine. 325:393-397. 1991
- Spurious hyperkalaemia associated with severe thrombocytosis and leukocytosis. Canadian Journal of Anaesthesia. 38:613-615. 1991
- Multimerin: a series of large disulfide-linked multimeric proteins within platelets. Blood. 77:2556-2560. 1991
- Reply. American Journal of Obstetrics and Gynecology. 164:1362-1363. 1991
- p-155, a multimeric platelet protein that is expressed on activated platelets.. Journal of Biological Chemistry. 266:7114-7120. 1991
- Heparin-induced thrombocytopenia.. Progress in hemostasis and thrombosis. 10:1-34. 1991
- Reply. American Journal of Obstetrics and Gynecology. 164:1362-1363. 1991
- Current Concepts in the Treatment of Immune Thrombocytopenia. Drugs. 40:531-542. 1990
- Low fetal risks in pregnancies associated with idiopathic thrombocytopenic purpura. American Journal of Obstetrics and Gynecology. 163:1147-1150. 1990
- Alloimmune neonatal thrombocytopenia associated with incidental maternal thrombocytopenia. American Journal of Hematology. 35:43-44. 1990
- Gova/b alloantigen system on human platelets. Blood. 75:2172-2176. 1990
- Gova/b alloantigen system on human platelets. Blood. 75:2172-2176. 1990
- Calpain proteolysis of von Willebrand factor enhances its binding to platelet membrane glycoprotein IIb/IIIa: an explanation for platelet aggregation in thrombotic thrombocytopenic purpura. British Journal of Haematology. 74:457-464. 1990
- Current Controversies Concerning the Measurement of Platelet-Associated IgG. Transfusion Medicine Reviews. 4:121-135. 1990
- Platelet Immunobiology. Transfusion Medicine Reviews. 4:85-86. 1990
- Plasma exchange in Canada. The Canadian Apheresis Study Group.. CANADIAN MEDICAL ASSOCIATION JOURNAL. 142:557-562. 1990
- Thrombocytopenia at delivery: A prospective survey of 6715 deliveries. American Journal of Obstetrics and Gynecology. 162:731-734. 1990
- Heparin and Platelets. Hematology/Oncology Clinics of North America. 4:243-264. 1990
- Adverse reactions in healthy blood donors undergoing plasmapheresis.. Progress in Clinical and Biological Research. 337:485-486. 1990
- Campylobacter Jejuni and Thrombotic Thrombocytopenic Purpura. Canadian Journal of Gastroenterology and Hepatology. 4:154-156. 1990
- The platelet aggregating factor(s) of thrombotic thrombocytopenic purpura.. Progress in Clinical and Biological Research. 337:141-149. 1990
- Platelet specific alloantigens on the platelet glycoprotein Ia/IIa complex. British Journal of Haematology. 72:534-538. 1989
- Use of Intravenous Gammaglobulin as an Immune Replacement and an Immune Suppressant. Transfusion Medicine Reviews. 3:82-120. 1989
- Heparin-Induced Thrombocytopenia. Annual Review of Medicine. 40:31-44. 1989
- A prospective comparison of four techniques for measuring platelet‐associated IgG. British Journal of Haematology. 71:97-105. 1989
- THROMBOCYTOPENIA DURING PREGNANCY - REPLY. New England Journal of Medicine. 319:1483-1483. 1988
- Thrombocytopenia during Pregnancy. New England Journal of Medicine. 319:1482-1483. 1988
- Intravenous IgG: A New Therapeutic Tool.. Canadian Family Physician. 34:2521-2365. 1988
- Heparin-induced thrombocytopenia: laboratory studies. Blood. 72:925-930. 1988
- Heparin-induced thrombocytopenia: laboratory studies. Blood. 72:925-930. 1988
- Incidentally Detected Thrombocytopenia in Healthy Mothers and Their Infants. New England Journal of Medicine. 319:142-145. 1988
- Neonatal alloimmune thrombocytopenia: Spontaneous in utero intracranial hemorrhage. American Journal of Hematology. 28:98-102. 1988
- Somatostatin Treatment for Cryptosporidial Diarrhea in a Patient with the Acquired Immunodeficiency Syndrome (AIDS). ACP journal club. 108:708-708. 1988
- PLASMA GLYCOCALICIN - REPLY. New England Journal of Medicine. 318:1071-1071. 1988
- Plasma Glycocalicin. New England Journal of Medicine. 318:1070-1071. 1988
- Methyldopa-induced autoantibodies against red blood cells. Blood Reviews. 2:36-42. 1988
- Hypergammaglobulinemia can be associated with a positive direct antiglobulin test, a nonreactive eluate, and no evidence of hemolysis. Transfusion. 28:29-33. 1988
- Anticonvulsant-Induced Marrow Suppression and Immune Thrombocytopenia. Acta Haematologica. 80:54-58. 1988
- IMMUNE THROMBOCYTOPENIA. ISI ATLAS OF SCIENCE-IMMUNOLOGY. 1:265-271. 1988
- Idiosyncratic Drug-Induced Thrombocytopenia1. Current Studies in Hematology and Blood Transfusion. 54:71-88. 1988
- Platelets and pregnancy. Contemporary Reviews in Obstetrics and Gynaecology. 1:26-35. 1988
- Acute Thrombocytopenia and Thrombosis. Annals of the New York Academy of Sciences. 509:205-221. 1987
- Calcium-dependent cysteine protease activity in the sera of patients with thrombotic thrombocytopenic purpura. Blood. 70:1683-1687. 1987
- Plasma Glycocalicin. New England Journal of Medicine. 317:1037-1042. 1987
- 111In-oxine platelet survivals in thrombocytopenic infants. Blood. 70:652-656. 1987
- A prospective study investigating the mechanism of thrombocytopenia in preeclampsia.. Obstetrics and Gynecology. 70:334-338. 1987
- IN-111 OXINE PLATELET SURVIVALS IN THROMBOCYTOPENIC INFANTS. Blood. 70:652-656. 1987
- Platelet and Red Cell Clearance Is Determined by the Interaction of the IgG and Complement on the Cells and the Activity of the Reticuloendothelial System. Transfusion Medicine Reviews. 1:75-84. 1987
- Relationship between platelet aggregating factor and von Willebrand factor in thrombotic thrombocytopenic purpura. British Journal of Haematology. 66:509-513. 1987
- Platelet IgG Fc receptor. American Journal of Hematology. 25:299-310. 1987
- Measurement of platelet-associated IgG in animal models of immune and nonimmune thrombocytopenia. Blood. 69:1294-1299. 1987
- DEEP VENOUS THROMBOSIS - WHEN TO START ORAL-THERAPY. Journal of the American Medical Association (JAMA). 257:2086-2087. 1987
- Clinical impact of neonatal thrombocytopenia. Journal of Pediatrics. 110:457-464. 1987
- Studies investigating platelet aggregation and release initiated by sera from patients with thrombotic thrombocytopenic purpura. Blood. 69:924-928. 1987
- Splenic function: physiology and splenic hypofunction. Critical Reviews in Oncology/Hematology. 7:1-36. 1987
- HLA TYPING, PLATELET ASSOCIATED IMMUNOGLOBULINS AND ANTICARDIOLIPIN ANTIBODY - REPLY. Journal of Rheumatology. 13:989-990. 1986
- Frequency and mechanism of neonatal thrombocytopenia. Journal of Pediatrics. 108:749-755. 1986
- CURRENT CLINICAL USES OF ANTIPLATELET DRUGS. Saudi Medical Journal. 7:200-200. 1986
- Bleeding time in hemophilia a: Potential mechanisms for prolongation. Journal of Pediatrics. 108:215-218. 1986
- METHYLDOPA AND RETICULOENDOTHELIAL FUNCTION - REPLY. New England Journal of Medicine. 314:249-249. 1986
- Methyldopa and Reticuloendothelial Function. New England Journal of Medicine. 314:248-249. 1986
- Platelet survival studies, An overview of the factors affecting the efficiency and reliability of platelet radiolabeling. Transfusion. 26:19-22. 1986
- A diagnostic test for heparin-induced thrombocytopenia. Blood. 67:27-30. 1986
- Heparin-Induced Thrombocytopenia. Seminars in Thrombosis and Hemostasis. 12:59-62. 1986
- Heparin-induced Thrombocytopenia. Pathophysiology of Haemostasis and Thrombosis: international journal on haemostasis and thrombosis research. 16:173-186. 1986
- Idiosyncratic Drug-Induced Thrombocytopenia1. Current Studies in Hematology and Blood Transfusion. NO. 52:104-114. 1986
- Platelet fragments do not contribute to elevated levels of platelet associated IgG. British Journal of Haematology. 61:707-715. 1985
- Granulocytes do not have surface ABO antigens. Transfusion. 25:567-569. 1985
- PLATELET AUTOANTIBODIES IN SEPTICAEMIA. British Journal of Haematology. 61:589-591. 1985
- Impaired Reticuloendothelial Function in Patients Treated with Methyldopa. New England Journal of Medicine. 313:596-600. 1985
- A Platelet Function Defect in Preeclampsia. Obstetric Anesthesia Digest. 5:98-98. 1985
- Platelet associated IgG--an overview.. Journal of Investigative Medicine. 33:383-387. 1985
- The concentration of IgG in the serum is a major determinant of Fc- dependent reticuloendothelial function. Blood. 66:490-495. 1985
- The concentration of IgG in the serum is a major determinant of Fc- dependent reticuloendothelial function. Blood. 66:490-495. 1985
- Correlation of a quinidine-induced platelet-specific antibody with development of thrombocytopenia. American Journal of Medicine. 79:253-255. 1985
- Advances in the Diagnosis and Management of ITP. Hospital Practice. 20:95-107. 1985
- Platelet-Aggregating Factor in Thrombotic Thrombocytopenic Purpura. ACP journal club. 102:560-560. 1985
- A Platelet Function Defect in Preeclampsia. Obstetric Anesthesia Digest. 5:98-98. 1985
- A platelet function defect in preeclampsia.. Obstetrics and Gynecology. 65:107-109. 1985
- Comparison of the measurement of surface or total platelet‐associated IgG in the diagnosis of immune thrombocytopenia. American Journal of Hematology. 18:1-5. 1985
- Current clinical uses of antiplatelet drugs. Saudi Medical Journal. 6:93-100. 1985
- Management of the Pregnant Patient with Idiopathic Thrombocytopenic Purpura. Obstetrical and Gynecological Survey. 40:30-32. 1985
- Quantitation of red cell‐associated IgG using an immunoradiometric assay. Transfusion. 24:473-476. 1984
- Detection of a Platelet-Agglutinating Factor in Thrombotic Thrombocytopenic Purpura. ACP journal club. 101:589-589. 1984
- ANGIOIMMUNOBLASTIC LYMPHADENOPATHY ASSOCIATED WITH RESERPINE. The Lancet. 324:820-821. 1984
- Blood component therapy.. Canadian Family Physician. 30:1809-1814. 1984
- A study of the bioavailability and platelet inhibitory effects of a new enteric-coated acetylsalicylic acid preparation. Thrombosis Research. 34:561-566. 1984
- Neonatal Thrombocytopenia. Clinics in Perinatology. 11:359-391. 1984
- The relationship among platelet-associated IgG, platelet lifespan, and reticuloendothelial cell function. Blood. 63:1434-1438. 1984
- The relationship among platelet-associated IgG, platelet lifespan, and reticuloendothelial cell function. Blood. 63:1434-1438. 1984
- Choice of Platelet Anticoagulants. ACP journal club. 100:613-613. 1984
- Clinical usefulness of testing for a heparin-dependent platelet-aggregating factor in patients with suspected heparin-associated thrombocytopenia.. Translational Research. 103:606-612. 1984
- Heparin-Associated Thrombocytopenia. ACP journal club. 100:535-535. 1984
- Studies on the frequency of heparin-associated thrombocytopenia. Thrombosis Research. 33:439-443. 1984
- HEPARIN-ASSOCIATED THROMBOCYTOPENIA - RESPONSE. Annals of Internal Medicine. 101:280-280. 1984
- Management of the Pregnant Patient with Idiopathic Thrombocytopenic Purpura. Obstetrical and Gynecological Survey. 39:30-31. 1984
- Management of the Pregnant Patient with Idiopathic Thrombocytopenic Purpura. ACP journal club. 99:796-796. 1983
- The production of platelet controls for assays quantitating platelet‐associated IgG. Transfusion. 23:516-518. 1983
- Substitution of the “group-and-screen” for the full crossmatch in elective operations. Canadian Journal of Anaesthesia. 30:641-645. 1983
- The effect of aspirin on the size of the hemostatic plug. Thrombosis Research. 32:267-273. 1983
- The amount of platelet-bound albumin parallels the amount of IgG on washed platelets from patients with immune thrombocytopenia. Blood. 62:924-927. 1983
- The amount of platelet-bound albumin parallels the amount of IgG on washed platelets from patients with immune thrombocytopenia. Blood. 62:924-927. 1983
- Quantitation of red cell membrane associated immunoglobulin in children with Plasmodium falciparum parasitaemia. British Journal of Haematology. 54:567-572. 1983
- Immune-mediated thrombocytopenia of malaria.. Journal of Clinical Investigation. 71:832-836. 1983
- Antiplatelet Agents: Rationale and Results. Clinics in Haematology. 12:311-354. 1983
- Dermatomyositis associated with platelet thrombi formation and responsive to antiplatelet therapy.. Journal of Rheumatology. 10:136-139. 1983
- PLATELET TRANSFUSIONS - A CRITICAL-APPRAISAL. Clinics in Oncology. 2:549-585. 1983
- The Measurement of Plateiet-Associated IgG Using an Immunoradiometric Assay. Journal of Immunoassay and Immunochemistry. 4:65-82. 1983
- The measurement of platelet-bound immunoglobulins: an overview of the methods and the biological relevance of platelet-associated IgG.. Progress in hematology. 13:163-199. 1983
- A prospective study of the usefulness of the measurement of platelet- associated IgG for the diagnosis of idiopathic thrombocytopenic purpura. Blood. 60:1050-1053. 1982
- The prenatal prediction of thrombocytopenia in infants of mothers with clinically diagnosed immune thrombocytopenia. American Journal of Obstetrics and Gynecology. 144:449-454. 1982
- Valproic acid and immune thrombocytopenia.. Archives of Disease in Childhood. 57:681-684. 1982
- Assessment of the optimal anticoagulant solution for storage of whole blood samples prior to measurement of platelet‐associated IgG. Transfusion. 22:295-297. 1982
- The quantitation of platelet-associated IgG on cohorts of platelets separated from healthy individuals by buoyant density centrifugation. Blood. 60:136-139. 1982
- The quantitation of platelet-associated IgG on cohorts of platelets separated from healthy individuals by buoyant density centrifugation. Blood. 60:136-139. 1982
- The relationship between the hemorrhagic and antithrombotic properties of low molecular weight heparin in rabbits. Blood. 59:1239-1245. 1982
- The amount of blood group A substance on platelets is proportional to the amount in the plasma. Blood. 59:980-985. 1982
- Sex related differences in platelet function: the effect of aspirin. Blood. 59:625-627. 1982
- The diagnostic value of the fibrinogen/fibrin fragment E antigen assay in clinically suspected deep vein thrombosis. Blood. 59:346-350. 1982
- Autoimmune Platelet Destruction: Idiopathic Thrombocytopenic Purpura. Seminars in Thrombosis and Hemostasis. 8:83-104. 1982
- Drug-Induced Platelet Destruction. Seminars in Thrombosis and Hemostasis. 8:116-137. 1982
- Infection-Induced Thrombocytopenia. Seminars in Thrombosis and Hemostasis. 8:217-233. 1982
- Thrombocytopenia in Preeclampsia and Eclampsia. Seminars in Thrombosis and Hemostasis. 8:234-247. 1982
- Sex-related differences in the efficacy of acetylsalicylic acid (ASA): The absorption of ASA and its effect on collagen-induced thromboxane B2 generation. Thrombosis Research. 24:163-168. 1981
- Drug-induced thrombocytopenia is associated with increased binding of IgG to platelets both in vivo and in vitro. Blood. 58:524-529. 1981
- Abnormal platelet function and arachidonate metabolism in chronic idiopathic thrombocytopenic purpura. Blood. 58:326-329. 1981
- Abnormal platelet function and arachidonate metabolism in chronic idiopathic thrombocytopenic purpura. Blood. 58:326-329. 1981
- The development and application of a serum assay for platelet-bindable IgG (S-PBIgG).. Translational Research. 98:272-279. 1981
- Acute calf pain and swelling in the arthritic patient: rupture of a popliteal cyst or deep venous thrombosis?. CANADIAN MEDICAL ASSOCIATION JOURNAL. 125:54-56. 1981
- Valproic acid and thrombocytopenia.. CANADIAN MEDICAL ASSOCIATION JOURNAL. 125:63-64. 1981
- The reversible binding of vinblastine to platelets: implications for therapy. Blood. 57:431-438. 1981
- Vaccination-Associated relapse of immune thrombocytopenia. Journal of the American Medical Association (JAMA). 245:369-370. 1981
- Relationship between the antithrombotic and anticoagulant effects of low molecular weight heparin. Thrombosis Research. 21:169-174. 1981
- Eradication of Rh hemolytic disease of the newborn.. CANADIAN MEDICAL ASSOCIATION JOURNAL. 123:1089-1091. 1980
- Bleeding associated with antithrombotic therapy.. Seminars in Hematology. 17:259-291. 1980
- Sex-related differences in platelet aggregation: influence of the hematocrit. Blood. 56:38-41. 1980
- Sex-related differences in platelet aggregation: influence of the hematocrit. Blood. 56:38-41. 1980
- Thrombocytopenia in septicemia: the role of disseminated intravascular coagulation. Blood. 56:88-92. 1980
- Neonatal Thrombocytopenia Due to Passive Immunization. New England Journal of Medicine. 302:1401-1403. 1980
- In Vitro Study of Drug-Induced Granulocytopenia. New England Journal of Medicine. 302:1151-1151. 1980
- A comparison of the quantitative ristocetin von willebrand factor assay by using fresh and fixed platelets. Thrombosis Research. 18:477-483. 1980
- Comparison of two direct assays for platelet-associated IgG (PAIgG) in assessement of immune and nonimmune thrombocytopenia. Blood. 55:424-429. 1980
- Comparison of two direct assays for platelet-associated IgG (PAIgG) in assessement of immune and nonimmune thrombocytopenia. Blood. 55:424-429. 1980
- Prostaglandin I2 (prostacyclin).. CANADIAN MEDICAL ASSOCIATION JOURNAL. 122:175-179. 1980
- DISSEMINATED INTRAVASCULAR PLATELET-AGGREGATION IN TTP AS THE PRIMARY PATHOLOGIC EVENT - AN ALTERNATIVE HYPOTHESIS. Seminars in Thrombosis and Hemostasis. 6:171-172. 1980
- Sex-related differences in platelet function in vivo following aspirin administration. Circulation. 62. 1980
- The relationship between the hemorrhagic and antithrombotic effects of standard and low molecular weight (LMW) heparins. Circulation. 62. 1980
- Platelet transfusions.. CANADIAN MEDICAL ASSOCIATION JOURNAL. 121:1353-1358. 1979
- The Use of in Vitro Technics to Study Drug-Induced Pancytopenia. New England Journal of Medicine. 301:621-624. 1979
- Exceptionally High Arterial Oxygen Tension in Diabetic Ketoacidosis. Southern Medical Journal. 72:1127-1128. 1979
- Leprosy's Footprints in Bone Marrow. New England Journal of Medicine. 301:272-273. 1979
- Platelet-Associated IgG in Septicemia. New England Journal of Medicine. 301:271-272. 1979
- Elevated Platelet-Associated IgG in the Thrombocytopenia of Septicemia. New England Journal of Medicine. 300:760-764. 1979
- Inappropriate antidiuretic hormone complicating histiocytic lymphoma. JAMA Internal Medicine. 139:307-308. 1979
- Comparison of the haemorrhagic effects of porcine and bovine heparin in rabbits. Thrombosis Research. 15:581-586. 1979
- The direct assay for platelet-associated IgG (PAIgG): lack of association between antibody level and platelet size. Blood. 53:73-80. 1979
- The direct assay for platelet-associated IgG (PAIgG): lack of association between antibody level and platelet size. Blood. 53:73-80. 1979
- Sex differences in the antithrombotic effects of aspirin. Blood. 52:1073-1076. 1978
- Sex differences in the antithrombotic effects of aspirin. Blood. 52:1073-1076. 1978
- Thrombogenic Effect of High-Dose Aspirin in Rabbits. Journal of Clinical Investigation. 62:892-895. 1978
- Comparison of Chemical Composition of Peritoneal Fluid and Serum. ACP journal club. 89:67-67. 1978
- A rapid method for the diagnosis of acute uric acid nephropathy. JAMA Internal Medicine. 138:612-615. 1978
- Digitalis Toxicity Manifested by Dysphagia. Journal of the American Medical Association (JAMA). 239:613-613. 1978
preprints
- Characteristics of anti-SARS-CoV-2 antibodies in recovered COVID-19 subjects 2020
- A Non-Inferiority Trial of Perioperative Eltrombopag or Intravenous Immune Globulin for Immune Thrombocytopenia 2020